1. Home
  2. SNPX vs BOXL Comparison

SNPX vs BOXL Comparison

Compare SNPX & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPX
  • BOXL
  • Stock Information
  • Founded
  • SNPX 2012
  • BOXL 1985
  • Country
  • SNPX United States
  • BOXL United States
  • Employees
  • SNPX N/A
  • BOXL N/A
  • Industry
  • SNPX Medicinal Chemicals and Botanical Products
  • BOXL Telecommunications Equipment
  • Sector
  • SNPX Health Care
  • BOXL Telecommunications
  • Exchange
  • SNPX Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • SNPX 3.7M
  • BOXL 4.0M
  • IPO Year
  • SNPX N/A
  • BOXL 2017
  • Fundamental
  • Price
  • SNPX $3.30
  • BOXL $0.91
  • Analyst Decision
  • SNPX Strong Buy
  • BOXL Buy
  • Analyst Count
  • SNPX 1
  • BOXL 2
  • Target Price
  • SNPX $14.00
  • BOXL $1.00
  • AVG Volume (30 Days)
  • SNPX 33.7K
  • BOXL 12.6M
  • Earning Date
  • SNPX 11-12-2024
  • BOXL 03-12-2025
  • Dividend Yield
  • SNPX N/A
  • BOXL N/A
  • EPS Growth
  • SNPX N/A
  • BOXL N/A
  • EPS
  • SNPX N/A
  • BOXL N/A
  • Revenue
  • SNPX N/A
  • BOXL $150,709,000.00
  • Revenue This Year
  • SNPX N/A
  • BOXL N/A
  • Revenue Next Year
  • SNPX N/A
  • BOXL $1.89
  • P/E Ratio
  • SNPX N/A
  • BOXL N/A
  • Revenue Growth
  • SNPX N/A
  • BOXL N/A
  • 52 Week Low
  • SNPX $2.32
  • BOXL $0.30
  • 52 Week High
  • SNPX $7.23
  • BOXL $2.13
  • Technical
  • Relative Strength Index (RSI)
  • SNPX 51.02
  • BOXL 58.40
  • Support Level
  • SNPX $3.10
  • BOXL $0.71
  • Resistance Level
  • SNPX $3.58
  • BOXL $2.13
  • Average True Range (ATR)
  • SNPX 0.33
  • BOXL 0.24
  • MACD
  • SNPX -0.03
  • BOXL 0.02
  • Stochastic Oscillator
  • SNPX 32.04
  • BOXL 31.15

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells and services interactive solutions predominantly for the education market, but also for the corporates and government sectors. The company currently designs, produces and distributes interactive technologies including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls and digital signage. The company also distributes science, technology, engineering and math (or STEM) products, including 3D printing and robotics solutions, and a portable science lab.

Share on Social Networks: